Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126680191	12668019	1	I	20160522	20160810	20160819	20160819	EXP	PB20160908	FR-MYLANLABS-2016M1034479	MYLAN		0.00				Y	0.00000		20160819		OT	FR	FR

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126680191	12668019	1	PS	KETOPROFEN MYLAN	KETOPROFEN	1	Intravenous (not otherwise specified)	50 MG, Q6H							74035	50	MG		Q6H
126680191	12668019	2	SS	KETOPROFEN MYLAN	KETOPROFEN	1	Oral	2 DF, QD							74035	2	DF		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126680191	12668019	1	Analgesic therapy

Outcome of event

Reactions reported

Event ID	CASEID	PT
126680191	12668019	Anaemia
126680191	12668019	Duodenal ulcer perforation
126680191	12668019	Hypotension
126680191	12668019	Peritonitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126680191	12668019	1	20160514	20160514	0
126680191	12668019	2	20160515	20160516	0